U.S. provides experimental Ebola treatment for outbreak in Congo, bringing trials closer

The U.S. had previously said that the antibody drug from Mapp Biopharmaceutical would only be made available to Americans deemed to be at high risk after exposure to the virus....

Redirecting to full article...